Healthcare - Biotechnology - NASDAQ - GB
$ 31.59
-3.16 %
$ 1.58 B
Market Cap
-34.34
P/E
BALANCE SHEET
597 M
ASSETS
228 M
LIABILITIES
369 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Immunocore Holdings plc
| Current Assets | 529 M |
| Cash & Short-Term Investments | 443 M |
| Receivables | 61.4 M |
| Other Current Assets | 24.8 M |
| Non-Current Assets | 68.2 M |
| Long-Term Investments | 0 |
| PP&E | 42.7 M |
| Other Non-Current Assets | 25.4 M |
| Current Liabilities | 139 M |
| Accounts Payable | 17.8 M |
| Short-Term Debt | 1.39 M |
| Other Current Liabilities | 120 M |
| Non-Current Liabilities | 89.1 M |
| Long-Term Debt | 82.6 M |
| Other Non-Current Liabilities | 6.49 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 442.6 | 332.5 | 237.9 | 129.7 | 74.0 | 124.4 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 61.4 | 27.8 | 24.8 | 2.1 | 1.5 | 46.1 |
| Inventory | 4.5 | 0.9 | (18.8) | (21.2) | (48.6) | (7.6) |
| Other Current Assets | 20.3 | 13.7 | 26.5 | 27.7 | 53.3 | 50.0 |
| Total Current Assets | 528.8 | 391.9 | 262.7 | 152.9 | 124.3 | 171.2 |
| PP&E | 42.7 | 31.6 | 31.5 | 36.8 | 54.9 | 20.9 |
| Intangible Assets | 0 | 410 | 0 | 0 | 0 | 0.3 |
| Goodwill | 0 | 0.4 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.1 | 4.9 | 1.0 | 0.6 | 0 |
| Other Long Term Assets | 14.5 | 7.2 | (31.5) | 4.2 | 4.4 | 2.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 597.0 | 435.5 | 301.8 | 197.2 | 185.6 | 195.8 |
| LIABILITIES | ||||||
| Accounts Payable | 17.8 | 14.4 | 10.1 | 7.9 | 15.7 | 6.4 |
| Short Term Debt | 1.4 | (15.9) | 10.3 | 12.6 | 21.1 | 0 |
| Other Current Liabilities | 118.0 | 58.1 | 45.8 | 36.5 | 47.1 | 42.4 |
| Total Current Liabilities | 139.0 | 83.1 | 61.2 | 55.0 | 84.5 | 49.6 |
| Long Term Debt | 82.6 | 31.8 | 84.5 | 84.3 | 38.3 | 18.9 |
| Deferred Tax Income | 0 | 0 | 0 | (24.9) | 0 | 0 |
| Other Liabilities | 1.0 | 36.7 | 8.7 | 34.1 | 48.1 | 70.7 |
| Total Liabilities | 228.2 | 156.8 | 130.2 | 141.8 | 170.9 | 139.2 |
| EQUITY | ||||||
| Common Stock | 0.1 | 97 K | 88 K | 1 K | 0 | 0 |
| Retained Earnings | (744.7) | (261.3) | (481.4) | (349.9) | (279.1) | (175.2) |
| Other Accumulative Comprehensive Income/Loss | (36.3) | 334.8 | 386.3 | 0.2 | 32 K | 67 K |
| Total Equity | 368.8 | 278.8 | 171.5 | 55.3 | 14.8 | 56.6 |
| Total Liabilities and Equity | 597.0 | 435.5 | 301.8 | 197.2 | 185.6 | 195.8 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 48.9 | 45.7 | 42.5 | 31.8 | 27.3 | 27.3 |